LOC653653 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.756000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.171800E-01
Normal-vs-Stage2
3.562200E-02
Normal-vs-Stage3
1.487820E-01
Normal-vs-Stage4
3.671400E-01
Stage1-vs-Stage2
9.396800E-01
Stage1-vs-Stage3
1.068220E-01
Stage1-vs-Stage4
6.134200E-01
Stage2-vs-Stage3
2.44019999999789E-05
Stage2-vs-Stage4
5.152200E-01
Stage3-vs-Stage4
1.967820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.045800E-02
Normal-vs-AfricanAmerican
4.245000E-01
Normal-vs-Asian
3.937700E-02
Caucasian-vs-AfricanAmerican
1.656850E-01
Caucasian-vs-Asian
2.004200E-01
AfricanAmerican-vs-Asian
1.136830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.098300E-02
Normal-vs-Female
7.650100E-02
Male-vs-Female
6.173900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.453600E-01
Normal-vs-Age(41-60Yrs)
1.391390E-01
Normal-vs-Age(61-80Yrs)
1.425640E-02
Normal-vs-Age(81-100Yrs)
1.776380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.049800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.506600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.349600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.206300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.656400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.049000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.704200E-03
Normal-vs-Daily Drinker
1.556190E-01
Normal-vs-Weekly Drinker
8.020200E-02
Normal-vs-Occasional Drinker
4.457600E-02
Normal-vs-Social Drinker
3.994800E-01
Non Drinker-vs-Daily Drinker
1.046180E-01
Non Drinker-vs-Weekly Drinker
4.619800E-01
Non Drinker-vs-Occasional Drinker
4.476400E-01
Non Drinker-vs-Social Drinker
1.187200E-01
Daily Drinker-vs-Weekly Drinker
1.073410E-01
Daily Drinker-vs-Occasional Drinker
5.716200E-02
Daily Drinker-vs-Social Drinker
2.803800E-02
Weekly Drinker-vs-Occasional Drinker
9.614000E-01
Weekly Drinker-vs-Social Drinker
3.333800E-01
Occasional Drinker-vs-Social Drinker
2.569400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.936600E-01
Normal-vs-Grade 2
8.284600E-01
Normal-vs-Grade 3
8.316800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.028400E-01
Grade 1-vs-Grade 3
9.448400E-01
Grade 1-vs-Grade 4
5.936600E-01
Grade 2-vs-Grade 3
9.524200E-01
Grade 2-vs-Grade 4
8.284600E-01
Grade 3-vs-Grade 4
8.316800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.106500E-02
Normal-vs-NonDiabetic
2.101900E-02
Diabetic-vs-NonDiabetic
8.613000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.600400E-02
Normal-vs-NoPancreatitis
1.917610E-02
Pancreatitis-vs-NoPancreatitis
7.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.214400E-02
Normal-vs-N1
3.600200E-02
N0-vs-N1
5.773000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.450030E-02
Normal-vs-TP53-NonMutant
9.962100E-02
TP53-Mutant-vs-TP53-NonMutant
6.827500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
